Edgewise Therapeutics's three largest insider shareholders as of April 28, 2026 are Holdings A/S Novo (TenPercentOwner, 6.07Mn shares), R Michael Carruthers (Chief Financial Officer, 86.16K shares), Kevin Koch (President And Ceo, 30.61K shares).
| Holder | Position | Shares (Direct) | Shares (Indirect) | Report Date |
|---|---|---|---|---|
| Holdings A/S Novo | - | 6,071,703 | 0 | 16 Sep, 2022 |
| R Michael Carruthers | Chief Financial Officer | 86,162 | 0 | 14 Aug, 2025 |
| Kevin Koch | President And Ceo | 30,615 | 0 | 14 Aug, 2025 |
| Jonathan C Fox | - | 24,514 | 0 | 03 Apr, 2026 |
| Behrad Derakhshan | Chief Business Officer | 23,645 | 0 | 14 Aug, 2025 |
| Alan J Russell | Chief Scientific Officer | 23,400 | 0 | 13 Nov, 2025 |
| John R Moore | General Counsel | 10,214 | 0 | 14 Aug, 2025 |
| Joanne M. Donovan | Cmo | 9,597 | 0 | 01 Apr, 2026 |
| Marc Semigran | Chief Development Officer | 6,716 | 0 | 27 Dec, 2024 |
* Please note that the shares above only reflect shares from the fund portfolio and the institutional portfolio. Shares from the personal portfolio are excluded from this Institutional Ownership Page. See these insiders' latest transactions here on Insider Page.
| Transaction Date | Insider Name | Security Class | Transaction Type | Shares Traded | Price | Shares Remaining | Ownership | Code |
|---|---|---|---|---|---|---|---|---|
| 01 Apr, 2026 | Jonathan C Fox | Common Stock | A | 339 | $0.00 | 24,514 | D | A |
| 01 Apr, 2026 | Joanne M. Donovan | Common Stock | A | 28,662 | $7.08 | 38,259 | D | M |
| 01 Apr, 2026 | Joanne M. Donovan | Common Stock | D | 28,662 | $32.31 | 9,597 | D | S |
| 01 Apr, 2026 | Joanne M. Donovan | Stock Option (Right to Buy) | D | 28,662 | $0.00 | 125,000 | D | M |
| 31 Mar, 2026 | Joanne M. Donovan | Common Stock | A | 21,338 | $7.08 | 30,935 | D | M |
| 31 Mar, 2026 | Joanne M. Donovan | Common Stock | D | 21,338 | $32.12 | 9,597 | D | S |
| 31 Mar, 2026 | Joanne M. Donovan | Stock Option (Right to Buy) | D | 21,338 | $0.00 | 153,662 | D | M |
| 27 Mar, 2026 | Joanne M. Donovan | Common Stock | D | 9,623 | $30.98 | 16,332 | D | S |
| 27 Mar, 2026 | Joanne M. Donovan | Common Stock | D | 6,735 | $30.98 | 9,597 | D | S |
| 02 Jan, 2026 | Jonathan C Fox | Common Stock | A | 473 | $0.00 | 24,175 | D | A |
| 12 Nov, 2025 | Alan J Russell | Common Stock | A | 100,000 | $0.18 | 123,400 | D | M |
| 11 Nov, 2025 | Jonathan C Fox | Common Stock | A | 10,700 | $18.64 | 23,702 | D | P |
| 10 Nov, 2025 | Michael Nofi | Restricted Stock Units | A | 43,750 | $0.00 | 43,750 | D | A |
| 12 Nov, 2025 | Alan J Russell | Common Stock | D | 100,000 | $21.12 | 23,400 | D | S |
| 10 Nov, 2025 | Michael Nofi | Stock Options (Right to buy) | A | 262,500 | $0.00 | 262,500 | D | A |
| 12 Nov, 2025 | Alan J Russell | Stock Option (Right to Buy) | D | 100,000 | $0.00 | 1,147,365 | D | M |
| 01 Oct, 2025 | Jonathan C Fox | Common Stock | A | 728 | $0.00 | 13,002 | D | A |
| 26 Aug, 2025 | Alan J Russell | Common Stock | A | 100,000 | $0.18 | 123,400 | D | M |
| 26 Aug, 2025 | Alan J Russell | Common Stock | D | 100,000 | $14.60 | 23,400 | D | S |
| 26 Aug, 2025 | Alan J Russell | Stock Option (Right to Buy) | D | 100,000 | $0.00 | 1,247,365 | D | M |